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Abstract
Background: Biomarkers of carotid atherosclerosis range from those that are widely available and
relatively simple to measure such as serum cholesterol levels, and B-mode Ultrasound
measurement of intima media thickness (IMT) to those that are more complex and technologically
demanding but perhaps potentially more sensitive and specific to disease such as total plaque
volume and total plaque area measured from 3-dimensional ultrasound images. In this study we
measured and compared intima media thickness (IMT), total plaque volume (TPV) and total plaque
area (TPA) in two separate populations, both vulnerable to carotid atherosclerosis.
Methods: In total, 88 subjects (mean age 72.8) with carotid stenosis of at least 60%, based on a
peak Doppler flow, and 82 subjects (mean age 60.9) with diabetic nephropathy were assessed in a
cross-sectional study. Conventional atherosclerotic risk factors were examined and the
associations and correlations between these and carotid ultrasound phenotypes measured from B-
mode and 3-dimensional ultrasound images were assessed.
Results: IMT and TPV were only modestly correlated in the two separate populations (r = .6, p <
.01). ANOVA analyses indicated that both IMT and TPV were significantly associated with age (p <
.001) and Framingham score (p < .05), but only TPV was associated with diabetes (p < .001) and
presence of plaque ulcerations (p < .01)
Conclusion: IMT and TPV were modestly correlated in a diabetic patient population and only TPV
was associated with diabetes and the presence of plaque ulcerations in a diabetic population and
carotid stenosis group. The 3-dimensional information provided by TPV can be critically important
in unmasking association with risk factors not observed with less complex single-dimension
assessments of carotid atherosclerosis such as those provided by IMT.
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Background
Measurements of atherosclerosis range from clinical
events such as myocardial infarction and stroke, and
biomarkers such as blood pressure, serum cholesterol and
triglycerides levels, to measurements acquired with non-
invasive imaging modalities such as computed tomogra-
phy (CT), magnetic resonance imaging (MRI) and ultra-
sound (US). Non-invasive imaging measurements can be
considered as physical characteristics or phenotypes that
can be measured in specific subjects and populations.
Such physical characteristics or phenotypes that are
shown to correlate with disease activity can be considered
to be disease biomarkers, and those biomarkers that can
be shown to correlate with clinical outcomes are consid-
ered as surrogate endpoints. Non-invasive imaging phe-
notypes are also of particular interest as they may reflect
different stages of or different underlying mechanisms
that contribute to atherogenesis; some of these pheno-
types directly reflect changes in plaque and atherosclerotic
vessel architecture providing a distinct advantage over
biochemical biomarkers from blood samples. Quantita-
tive assessment of different non-invasive imaging pheno-
types in different vulnerable patient populations is an
important approach to understanding natural disease pro-
gression and treatment-related disease regression.
An emerging imaging phenotype of atherosclerosis is
carotid total plaque volume (TPV), measured with three-
dimensional ultrasound and specialized image processing
software [1]. The current widely-accepted non-invasive
measurement of atherosclerosis based on measurement of
one-dimensional thickening of the artery wall is intima-
media thickness (IMT). While IMT measurements have
been validated in many studies, it is important to
acknowledge that many distinct cellular, biological and
pathological pathways and mechanisms may be reflected
by the measurement. For example, a measurement of IMT
may represent hypertensive medial hypertrophy [2,3],
compensatory intimal thickening due to mechanical
forces of blood flow [4,5], or the initial "fatty streak" stage
of atherosclerosis that involves accumulation of macro-
phage foam cells in the artery wall [6]. Moreover, the
intima and media also change over time in response to a
variety of factors, some of these not necessarily related to
atherosclerotic plaque formation and progression.
Carotid TPV is a direct 3-dimensional (3D) measurement
of atherosclerotic plaque burden, and directly assesses
atherogenesis when lesions develop beyond the initial
fatty streak to the atheroma classification. The direct
measurement of plaque volume itself would be expected
to be highly sensitive and specific to atherosclerosis dis-
ease progression. Indeed, three-dimensional volumetric
measurements of plaque provide enhanced "dynamic
range" over the one-dimensional IMT measurement [7].
In this study we aimed to measure and compare total
plaque volume (TPV), total plaque area (TPA) and intima-
media thickness (IMT) in the carotid arteries, as well as
previously established biomarkers, in two special and vul-
nerable populations: middle-aged patients with diabetic
nephropathy and elderly patients with asymptomatic
carotid stenosis of at least 60%. Imaging measurements of
atherosclerosis that we continue to develop and validate
are assessed in these populations to better understand the
associations of these with one another and with risk fac-
tors related to atherosclerosis progression.
Methods
Study sample
One study population consisted of 88 subjects with inter-
nal carotid artery stenosis (carotid stenosis population) of
at least 60%, based on a peak Doppler flow velocity cut-
off established by the North American Carotid Endarterec-
tomy Trial (NASCET) [8]. These subjects regularly
attended the Stroke Prevention and Atherosclerosis
Research Centre (SPARC) at Robarts Research Institute;
they were participants in a long-term study to investigate
imaging methods that may reveal vascular phenotypes
associated with cardiovascular events. Although some
subjects had a history of transient ischemic attacks, all
patients had been asymptomatic for at least 18 months
prior to beginning the study. The comparison population
consisted of 82 patients with clinical diagnosis of diabetic
nephropathy (diabetic population). Subjects were
recruited among patients who regularly attended the
Nephrology or Diabetes Clinics of the London Health Sci-
ences Centre and participated in a long-term placebo-con-
trolled trial investigating the effects of vitamin therapy on
plasma homocysteine reduction. Both cohorts underwent
3D and standard B-mode ultrasound scans of the carotid
arteries. All subjects provided written informed consent to
protocols approved by The University of Western Ontario
Health Sciences Research Ethics Board.
Risk factors and biochemical determinations
Clinical data collected and used in the analysis of both
populations were age, sex, body mass index (BMI),
plasma cholesterol, low-density lipoproteins (LDL), high-
density lipoproteins (HDL) and triglycerides, blood pres-
sure (BP), number of plaque ulcerations, diabetes status
and smoking history. Age, sex, height and weight were
self-reported. For both cohorts, blood pressure was meas-
ured once in one arm (the one arm previously determined
to have the highest pressure), as many as three times. The
average of multiple measurements was used. Subjects with
physician-diagnosed diabetes were considered to be dia-
betic. Smokers were defined as those who currently
smoked or those who had stopped smoking less than one
year prior to the ultrasound scan. Blood for biochemical
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measurements included triglycerides, total cholesterol,
HDL and LDL. Framingham risk scores [9], defined as the
percent risk of experiencing a coronary heart disease event
within 10 years, were calculated for each patient. Coro-
nary heart disease events were defined as myocardial inf-
arction, angina or sudden death. The risk score calculation
included the following parameters: age, sex, LDL, HDL,
BP, presence of diabetes and smoking status. In the dia-
betic population, for 10 subjects for whom LDL data was
not available, an alternative calculation with total choles-
terol values was used. A Framingham risk score was not
calculated for four subjects who did not have HDL results.
Clinical data for the asymptomatic stenosis cohort were
collected up to six months prior to ultrasound scanning,
whereas clinical data for the diabetic population were col-
lected at the time of the ultrasound scans.
General ultrasound logistics
Ultrasound (US) images were acquired with an HDI 5000
duplex machine and an L12-5 transducer (both from
Advanced Technology Laboratories, Bothell, WA USA). A
single experienced sonographer acquired images suitable
for determination of IMT, TPA and TPV.
Intima-Media Thickness (IMT) data acquisition and 
measurement
Ultrasound images were acquired from an anterolateral
longitudinal view and saved to S-VHS tapes. The sonogra-
pher used the minimum gain necessary to clearly visualize
lumen-intima and media-adventitia echoes, which are of
best quality when the image plane is parallel to the carotid
artery axis. These views were reviewed using an image
processing board and a specialized recorder with digital
memory permitting digitization of a full video frame in
"still" mode. The resultant digitized ultrasound images,
captured at end-diastole, were analyzed using Prowin [10]
edge-detection software. Two to six points were placed
manually on each of the lumen-intima and media-adven-
titia boundaries on the far wall of the artery using a mouse
driven cross-haired cursor. The software algorithm func-
tions by deleting weak edge points and filling boundary
gaps by linear interpolation. Mean IMT is then computed
from 80 to 120 measurements over a 10-mm span ending
5 mm proximal to the transition between the common
carotid and bulb regions. Mean IMT was the average of the
measurements from the left and right carotid arteries.
Measurements were made by a single reader, (SAR), and
resulted in an intra-reader intraclass correlation (ICC) of
0.92. The ICC was determined from 20 images measured
twice, two weeks apart.
Total Plaque Area (TPA) measurement
Plaque area measurements were made by a trained sonog-
rapher on magnified, longitudinal views of the common
carotid arteries in real time. The patient was scanned until
the largest extent of a plaque could be seen, and the image
was used to outline plaque with the use of a trackball and
the area was immediately calculated by the microproces-
sor in the scanner. Plaque was defined as a local thicken-
ing of the intima layer of greater than 1 mm [11]. This was
repeated for all plaques in the common, external and
internal carotids. TPA was the sum of all plaques between
the clavicle and the angle of the jaw in both left and right
carotid arteries. Measurements were made by one reader,
and resulted in an ICC of 0.94. This ICC was determined
by scanning the same 25 subjects twice, one week apart.
Total Plaque Volume (TPV) measurement
3D US images were viewed and analyzed using 3D Quan-
tify software [12]. The protocol for measuring plaque vol-
ume involved outlining the vessel on sequential
transverse slices and using the contours to locate the
carotid bifurcation, which was then marked with a single
point using a mouse driven cursor. A 2.0 cm axis was then
set along the length of the vessel, +/- 1.0 cm from the
carotid bifurcation. Plaque was outlined on sequential
transverse slices by manually clicking a mouse driven cur-
sor at regular intervals around the plaque. Measurements
were made at 1.0 mm increments along the axis of the ves-
sel, an interslice distance which has been shown to opti-
mize accuracy and reliability [1]. TPV was determined by
summing the calculated areas in each slice over the 2.0 cm
region and multiplying by the interslice distance. All
measurements were made by a single reader. Intra-reader
ICC was 0.91, based on five images read five times at one-
week intervals.
Plaque ulceration scoring
Plaque ulcerations in the common and internal carotid
arteries were scored by a single observer. Plaque ulcera-
tions were identified as focal defects in plaque surface of
at least 0.5 mm in depth, length and width that were visi-
ble from multiple angles. Subjects were scored as positive
if at least a single ulceration was observed in the 3D US
image.
Statistical analyses
Data analysis was conducted with statistical software SPSS
version 12.0 (SPSS Inc., 2003). Associations between the
different ultrasound measures of atherosclerosis were
determined using the Pearson product-moment correla-
tion. For the asymptomatic stenosis population, the corre-
lation was determined between TPA and TPV. For the
diabetic nephropathy population, correlations were deter-
mined between IMT, TPA and TPV. Distributions were sig-
nificantly non-normally distributed and therefore, IMT
TPA and TPV variables were transformed and subjected to
analysis of normality. After transformation, the inverse of
IMT, and cubed root of both TPV and TPA were normally
distributed. The transformed variables were used for theCardiovascular Ultrasound 2006, 4:44 http://www.cardiovascularultrasound.com/content/4/1/44
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analyses. Simple linear regressions were performed pre-
dicting the inverse of IMT, the TPV and TPA transformed
by cube root, using a number of dichotomous and contin-
uous predictors: age, sex, BMI, BP, number of ulcerations,
diabetes and smoking history, and Framingham score.
This analysis was conducted for the populations as a
whole, as well as for subpopulations characterized by sex
and, in the diabetic cohort, diabetes type. A significant
result indicates that there is a significant difference
between the categories from the dichotomous and contin-
uous variables with respect to the phenotypes measured.
Results
Baseline demographic features
Clinical attributes for the two subject populations, as a
whole and by sex, are provided in Table 1. The two popu-
lations differed significantly in both discrete and quanti-
tative traits. The mean age of the asymptomatic stenosis
population was 72.8 ± 8.6 years, which was significantly
older than the mean age of the diabetic nephropathy pop-
ulation (60.9 ± 11.2 years). TPA and TPV for the stenosis
population were both significantly greater than the corre-
sponding measurements in the diabetic population. Mean
TPA was 2.5 times greater and mean TPV was 4.2 times
greater in the carotid stenosis cohort as compared to the
diabetic cohort. Mean IMT, which was not measured in
the carotid stenosis population, was 0.87 ± 0.17 mm in
the diabetic population. The populations also differed
with respect to plaque ulcerations, in that just over half of
the carotid stenosis population showed 3D US evidence
of at least a single plaque ulceration. The proportion of
diabetics in each population was significantly different
with 17.0% of the stenosis population reporting physi-
cian-diagnosed type 2 diabetes and the diabetic nephrop-
athy population consisted of a combination of type 1 and
type 2 diabetics, at 17.1% and 82.9%, respectively. The
diabetic population had significantly BMI, total choles-
terol and triglycerides than the carotid stenosis popula-
tion. Although the diabetic nephropathy cohort was
much younger, Framingham scores were greater than two-
fold higher as compared to the carotid stenosis popula-
tion. Significant differences between males and females in
each population were identified for smoking. Also, in the
carotid stenosis population, females had both lower TPV
and TPA than males.
Carotid ultrasound data
Figure 1 shows representative ultrasound images for sub-
jects evaluated in this study. Figure 1A shows an IMT
measurement from a B-mode ultrasound image in the
longitudinal view with the carotid bifurcation clearly
identified (BF). As shown, IMT measurements are made in
the longitudinal view on the far wall (from the ultrasound
transducer) and the semi-automated 1-dimensional
measurement is defined by the red line between the
intima-lumen boundary and the media-adventitia bound-
ary. Figure 1B shows a TPA measurement from a B-mode
US image with the manually outlined plaque area shown
in the longitudinally view. Figure 1C shows a cross-sec-
tional or axial view of the internal and external carotid
artery with manual TPV measurements in both branches
of the artery and the bifurcation identified as BF.
Table 1: Baseline demographics of 88 asymptomatic carotid stenosis and 81 diabetic nephropathy study subjects.
Asymptomatic 
Stenosis All




No. 88 63 24 82 55 27
Female 27.3% 32.9%
Current Smoking 19.3% 23.4%t 8.3%t 13.4% 16.4% 7.4%
Type 1 Diabetes** 0.0 0 0 17.1% 14.5% 22.2%
Type 2 Diabetes** 17.0% 18.8% 12.5% 82.9% 85.5% 77.8%
Cholesterol Lowering Treatment n(%) 80.5 (82) 83.1 73.9 70.7
Hypertension Treatment n (%) 92.7 (82) 91.5 95.7 98.8
≥ 1 Ulceration (%)** 51.1 51.6 50.0 11.0 10.0 11.1
Quantitative Traits (mean+/- SD
Age (y)** 72.8 ± 8.6 73.1+/-8.2 72.0+/-9.6 60.9 ± 11.2 61.2+/-11.2 60.3+/-11.4
BMI (kg/m2)** 26.4 ± 4.0 (81) 26.6 +/-3.6 26.0+/-5.0 33.2 ± 5.9 32.6+/-5.6 34.3+/- 6.6
Total Chol (mmol/L)** 4.38 ± 0.94 4.27+/-0.96 4.64+/-0.85 4.95 ± 1.56 (80) 4.65+/-1.34t 5.57+/-1.81t
Triglycerides (mM)** 1.46 ± 0.57 1.40+/-0.56 1.64+/-0.56 2.64 ± 1.81 (78) 2.43+/-1.36 3.06+/-2.47
Framingham Score (%)** 8.3 ± 4.4 8.0 +/-4.1 9.3+/-5.2 19.6 ± 11.4 (78) 21.3+-12.6t 16.2+7.9t
Carotid IMT (mm) ND ND ND 0.87 ± 0.17 0.88+/-0.15 0.84+/-0.20
Carotid TPA (cm2)** 3.4 ± 1.8 3.8+/-1.8** 2.4+/-1.5** 1.3 ± 1.2 1.4+/-1.0 1.3+/-1.5
Carotid TPV (mm3)** 690 ± 330 790+/-330** 420+/-150** 160 ± 170 180+/-170 120+/-150
** difference is significant at the 0.01 level; t difference is significant at 0.05 level IMT, mean carotid intima-media thickness of measured right and 
left carotid IMT; TPV, total volume of carotid plaque burden: sum of plaque volume from right and left carotid; TPA, total plaque area ; Type 1 and 
Type 2 diabetes refers to physician-diagnosed diabetes; Lipid-lowering and antihypertensive medication history was retrieved from physician chart; 
The numbers in brackets indicate the sample size for which the given trait was calculated due to unavailable data.Cardiovascular Ultrasound 2006, 4:44 http://www.cardiovascularultrasound.com/content/4/1/44
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IMT data are provided in Table 1 for the diabetic nephrop-
athy population. There were no differences in IMT meas-
urements for males and females. TPA and TPV
measurements for both the carotid stenosis and diabetic
nephropathy population are also provided in Table 1 and
for the carotid stenosis population only, TPA and TPV
measurements were greater in males than in females.
Pearson correlation coefficients between transformed
IMT, TPA and TPV are shown in Table 2. For the carotid
stenosis population, correlations between TPA and TPV
were modest and significant. For the diabetic nephropa-
thy population (see Figure 2), IMT correlations with TPA
and TPV were modest (r = -.600 and -.606 respectively)
and significant while TPA-TPV correlations where high (r
= .851) and significant.
Correlations with demographic features
As shown in Table 3, simple linear regressions were per-
formed predicting the inverse IMT as well as TPV and TPA
transformed by cube root, using a number of dichoto-
mous and continuous predictors. ANOVA analyses indi-
cated that transformed IMT was significantly associated
with age (p < .001), diastolic BP (p < .01) and Framing-
ham score (p < .05) for the diabetic population and TPV
and TPA were both significantly associated with age (p <
.001), diabetes (p < .001), presence of plaque ulcerations
(p < .01) and Framingham score (p < .01). The same anal-
ysis of the carotid stenosis population revealed that both
TPA and TPV were significantly associated with sex (p <
.001) and presence of ulcerations (p < .01). In the younger
diabetic population, all carotid ultrasound phenotypes
were significantly associated with age and Framingham
score, whereas in the older carotid stenosis population,
only sex (male) and presence of ulcerations were signifi-
Table 2: Carotid ultrasound phenotype correlations
Carotid Stenosis IMT TPA TPV
IMT
TPA 10 . 5 9 8
TPV 1
Diabetic Nephropathy 1/IMT TPA1/3 TPV1/3
IMT (inverse) 1 -0.606 -0.600
TPA (cube root) 10 . 8 5 1
TPV (cube root) 1
All correlations significant at the 0.01 level. TPA and TPV in the 
carotid stenosis population were normally distributed. Inspection for 
skewness and kurtosis revealed significantly non-normal distributions 
for IMT, TPA and TPV in the diabetic nephropathy population. These 
variables were transformed to produce distributions that did not 
deviate significantly from normal. Inverse transformation was used for 
IMT (1/IMT) and cube root transformation was used for area and 
volume measurements (TPA1/3 and TPV1/3).
Carotid atherosclerosis imaging phenotypes Figure 1
Carotid atherosclerosis imaging phenotypes. A) IMT measure-
ment from a B-mode ultrasound image in the longitudinal view with 
the carotid bifurcation identified as BF. B) TPA measurement from a 
longitudinal B-mode US image with the outlined plaque area shown in 
white. C) cross-sectional or axial view of the internal and external 
carotid artery with manual TPV measurements in both branches of 
the artery and the bifurcation marked BF.Cardiovascular Ultrasound 2006, 4:44 http://www.cardiovascularultrasound.com/content/4/1/44
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cant predictors of TPA and TPV. Since there was a correla-
tion between TPA and TPV and diabetes, subpopulations
of the diabetic nephropathy cohort were assessed with
respect to diabetes type. While mean age for type 2 diabet-
ics (n = 68) was 63.8 ± 9.0 years, type 1 diabetics (n = 14)
were significantly younger with mean age 47.0 ± 10.8
years. TPA and TPV for type 2 diabetics (1.46 ± 1.23 cm2
and 187 ± 170 mm3, respectively) were significantly
greater than for type 1 diabetics (TPA 0.74 ± 0.83 cm2 and
TPV 47.2 ± 55.6 mm3). The two subgroups, however, did
not significantly differ in mean IMT. As this and previous
work shows that age is predictive of TPA and TPV in
younger populations, TPA and TPV were reassessed for
correlations with of diabetes type while controlling for the
mean age difference between type 1 and type 2 diabetics.
In this analysis we found that TPV was not significant (p <
0.088) and neither was TPA (p < 0.959). As the TPV result
approached significance, a sample size calculation was
performed to determine how many individuals would be
required to achieve significant differences (power of 0.8
and an alpha of 0.05) and this indicated that 216 subjects
across diabetes types would be required to detect group
differences when controlling for age.
Discussion
IMT measurements has been used for many years in the
assessment of carotid atherosclerosis; IMT image acquisi-
tion and analysis is relatively straightforward and pro-
vides a one-dimensional measure of carotid artery wall
changes. However, different multi-dimensional methods
of measuring atherosclerosis may potentially provide bio-
logically distinct and perhaps more sensitive and specific
measures of carotid atherosclerosis [13]. For example, in a
previous study at our centre, we found that traditional risk
factors accounted for 52% of variance of carotid plaque
area [14] and 13% of variance of carotid stenosis, whereas
O'Leary et al found that these accounted for 15–17% the
variance of carotid IMT [15]. This suggests that the differ-
ent phenotypes reflect different biological mechanisms
related to atherosclerosis. IMT, for example, constitutes
approximately 80% media and 20% intima [16]. Thus,
IMT measurements represent medial hypertrophy in addi-
tion to atherosclerosis, introducing blood pressure-related
effects as well as atherosclerosis-related effects in IMT
measurement values
Hegele and collaborators first showed that different
atherosclerosis phenotypes associate with different risk
factors in a closed aboriginal population [17]. In their
analysis of a subject population distinct from the two
cohorts studied here, ultrasound phenotype correlations
were similar to those found in our analysis of middle-aged
diabetics and elderly with carotid stenosis; IMT was found
to be associated with age and hypertension, and TPV with
age and the presence of diabetes. Different associations
between phenotypes with PPARG genotypes and PCK1
variants were also identified [17-20] and TPV in particular
was increased over a seven year period for type 2 diabetic
subpopulation of the cohort [7]. Our analysis of two addi-
tional vulnerable populations extends these landmark
findings and further suggests that IMT and TPV may rep-
resent different stages of atherosclerosis and may also
reflect different biological and genetic contributions to, or
attributes of, the atherosclerotic process. The fact that in
both populations, 2-dimensional and 3-dimensional
ultrasound phenotypes associate significantly with plaque
ulcerations also suggests these are related to plaque vul-
nerability in both middle-aged diabetics and elderly sub-
jects with carotid stenosis.
Ultrasound phenotype correlations for diabetic nephropathy  population Figure 2
Ultrasound phenotype correlations for diabetic neph-
ropathy population. A) Pearson Correlation for IMT and 
TPV in diabetic subgroup and B) Pearson Correlation for 
TPA and TPV in diabetic subgroup.Cardiovascular Ultrasound 2006, 4:44 http://www.cardiovascularultrasound.com/content/4/1/44
Page 7 of 9
(page number not for citation purposes)
Overall these results suggest that in different subject pop-
ulations, both vulnerable to vascular disease, carotid
ultrasound phenotypes associate differently with various
risk factors. Differences were observed as well in that TPA
and TPV in both populations were associated with ulcera-
tions, whereas IMT was not associated with plaque ulcer-
ations for the diabetic population where IMT was
measured. Moreover, for the diabetic population, only
TPA and TPV were significantly associated with diabetes
type, and not IMT. This suggests that advanced plaque
development that is reflected in measurements of TPA and
TPV is associated with type 2 diabetes and that the pres-
ence of type 2 diabetes may play a role in mechanisms
contributing to plaque burden, but not contributing spe-
cifically to IMT.
Conclusion
Here we extend the first reported comparisons of imaging
phenotypes of atherosclerosis by Hegele and collabora-
tors [7,17-20] and report: 1) correlations between the
ultrasound imaging phenotypes of atherosclerosis, 2)
relationships between risk factors and US phenotypes,
Table 3: Determinants of carotid ultrasound traits
Diabetic Nephropathy Carotid Stenosis
Source of Variation Degrees Freedom F P > F Degrees of Freedom F P > F
Dependent Variable: mean inverse carotid intima media thickness
Age 1 20.95 <0.001
Sex 1 2.49 NS (0.11)
BMI 1 0.28 NS (0.59)
Diabetes 1 2.66 NS (0.10)
Current Smoking 1 0.10 NS (0.75)
Systolic BP 1 1.46 NS (0.22)
Diastolic BP 1 10.34 <0.01
Presence Ulcers 1 3.15 NS (0.07)
Framingham Score 1 4.55 <0.05
Dependent Variable: mean cubed root total plaque volume
Age 1 29.15 <0.001 1 0.67 NS (0.41)
Sex 1 3.44 NS (0.06) 1 29.94 <0.001
BMI 1 0.52 NS (0.47) 1 0.002 NS (0.96)
Diabetes 1 17.71 <0.001 1 0.09 NS (0.75)
Current smoking 1 0.01 NS (0.73) 1 0.25 NS (0.61)
Systolic BP 1 0.98 NS (0.32) 1 0.01 NS (0.91)
Diastolic BP 1 1.96 NS (0.16) 1 0.84 NS (0.36)
Presence Ulcers 1 7.55 <0.01 1 9.27 <0.01
Framingham Score 1 11.17 <0.01 1 0.12 NS (0.72)
Dependent Variable: mean cubed root total plaque area
Age 1 22.20 <0.001 1 0.187 NS (0.66)
Sex 1 1.50 NS (0.22) 1 16.49 <0.001
BMI 1 0.59 NS (0.59) 1 0.11 NS (0.73)
Diabetes 1 6.16 <0.05 1 1.06 NS (0.30)
Current Smoking 1 0.04 NS (0.82) 1 2.65 NS (0.10)
Systolic BP 1 0.13 NS (0.71) 1 0.10 NS (0.74)
Diastolic BP 1 3.58 NS (0.06) 1 0.07 NS (0.78)
Presence Ulcers 1 15.01 <0.001 1 10.75 <0.01
Framingham Score 1 6.29 <0.05 1 0.10 NS (0.74)Cardiovascular Ultrasound 2006, 4:44 http://www.cardiovascularultrasound.com/content/4/1/44
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and 3) comparison of associations between US pheno-
types in two significantly different vulnerable patient
groups.
While the mean age of the carotid stenosis cohort was
nearly 12 years older, mean TPA and TPV were 2.5 and 4.2
fold greater than in the younger diabetic cohort and over
half the older cohort showed 3D US evidence of at least
one ulcer. In the older stenosis population only, females
had statistically significantly lower mean TPA and TPV
compared to males. Although the diabetic nephropathy
cohort was much younger, Framingham scores were
greater than two-fold overall risk as compared to the older
stenosis cohort.
Hegele and collaborators showed that for a middle-aged
aboriginal population (Sandy Lake Canada) carotid IMT
was associated with age and hypertension, whereas TPV
was associated with age and the presence of diabetes. In
our analysis, IMT was significantly associated with age,
diastolic BP and Framingham score, but not diabetes. TPV
and TPA were significantly associated with age and diabe-
tes and with the presence of ulcerations and Framingham
score. For the elderly population with significant carotid
stenosis, both TPA and TPV were significantly associated
with sex and presence of ulcerations. Such differences in
risk factor and ultrasound phenotypes in different popu-
lations create a framework for understanding risk factor
relationships in middle age and elderly populations
Because different phenotypes may be related to different
biological and genetic factors, the use of these phenotypes
as measurement tools may provide for a wide range of
sensitivities and specificities to disease progression and
regression that is population-dependent. While our sam-
ple sizes are small, our results suggest that while imaging
measures themselves correlate similarly across diverse
populations, a given imaging measures associates with
different risk factors in different populations. We suggest
that clinical studies that aim to use imaging measures as
surrogate endpoints should measure specific biomarkers
that are dependent on the treatment and specific popula-
tion being studied. It may be necessary for specific new
interventions to be targeted to specific study populations
that are well characterized with respect to genotype, phe-
notype or other underlying characteristics. Study popula-
tions may need to be targeted based on the likelihood of
well-characterized treatment effects that can be predicted
in advance using the approaches we have taken here.
While all of these issues require clarification in the future,
it is clear that individual imaging measures such as IMT,
TPA and TPV will require rigorous testing and validation
in specific target populations before they can be used as
surrogate endpoints in treatment studies.
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